AAREYDRUGS Q1 FY27 results at a glance
AAREY DRUGS & PHARM LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹44.63 cr |
|---|
| Revenue YoY | -56.3% |
|---|
| Operating profit | ₹0.48 cr |
|---|
| Operating margin | 1.1% |
|---|
| Net profit | ₹1.02 cr |
|---|
| Net profit YoY | -25.3% |
|---|
| Net profit QoQ | -34.3% |
|---|
| Net margin | 2.3% |
|---|
| Basic EPS | ₹0.36 |
|---|
| TTM revenue | ₹415 cr |
|---|
| TTM net profit | ₹4.17 cr |
|---|
| TTM net margin | 1.0% |
|---|
AAREYDRUGS Q1 FY27 results: what the numbers say
AAREY DRUGS & PHARM LTD (AAREYDRUGS) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹44.63 cr and a net profit of ₹1.02 cr, translating into earnings per share of ₹0.36.
Compared with the same quarter a year earlier, revenue declined sharply by -56.3% and net profit declined strongly by -25.3%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹0.48 cr, an operating margin of 1.1% versus 1.2% a year ago — a contraction of 0.1 percentage points.
AAREYDRUGS quarter-wise results table
Revenue
₹44.63 cr
-56.3% YoY
Net profit
₹1.02 cr
-25.3% YoY
Operating profit
₹0.48 cr
-61.0% YoY
AAREY DRUGS & PHARM LTD (AAREYDRUGS) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹44.63 cr | ₹0.48 cr | ₹1.02 cr | 1.1% | 2.3% | ₹0.36 | -25.3% | -34.3% |
| Q4 FY262026-03-31 | ₹189 cr | ₹3.49 cr | ₹1.56 cr | 1.8% | 0.8% | ₹0.55 | — | +173.5% |
| Q3 FY262025-12-31 | ₹96.43 cr | -₹2.34 cr | ₹0.57 cr | -2.4% | 0.6% | ₹0.20 | — | -44.4% |
| Q2 FY262025-09-30 | ₹84.16 cr | ₹1.95 cr | ₹1.02 cr | 2.3% | 1.2% | ₹0.36 | — | -25.3% |
| Q1 FY262025-06-30 | ₹102 cr | ₹1.22 cr | ₹1.37 cr | 1.2% | 1.3% | ₹0.48 | — | — |
| TTM (last 4 quarters) | ₹415 cr | ₹3.58 cr | ₹4.17 cr | 0.9% | 1.0% | ₹1.47 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
AAREYDRUGS quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
AAREY DRUGS & PHARM LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹44.63 cr | ₹189 cr | ₹96.43 cr | ₹84.16 cr | ₹102 cr |
|---|
| Total expenses | ₹44.15 cr | ₹186 cr | ₹98.77 cr | ₹82.21 cr | ₹101 cr |
|---|
| Gross profit | ₹2.47 cr | ₹10.08 cr | -₹0.37 cr | ₹3.68 cr | ₹4.37 cr |
|---|
| Operating profit (EBIT) | ₹0.48 cr | ₹3.49 cr | -₹2.34 cr | ₹1.95 cr | ₹1.22 cr |
|---|
| Operating margin | 1.1% | 1.8% | -2.4% | 2.3% | 1.2% |
|---|
| Interest cost | ₹1.67 cr | ₹1.78 cr | ₹0.92 cr | ₹1.26 cr | ₹1.04 cr |
|---|
| Profit before tax | ₹0.52 cr | ₹1.28 cr | ₹0.92 cr | ₹1.48 cr | ₹1.73 cr |
|---|
| Tax expense | -₹0.51 cr | -₹0.28 cr | ₹0.35 cr | ₹0.46 cr | ₹0.36 cr |
|---|
| Effective tax rate | -98.5% | -21.7% | 38.3% | 30.9% | 20.7% |
|---|
| Net profit (PAT) | ₹1.02 cr | ₹1.56 cr | ₹0.57 cr | ₹1.02 cr | ₹1.37 cr |
|---|
| Net profit margin | 2.3% | 0.8% | 0.6% | 1.2% | 1.3% |
|---|
| Basic EPS | ₹0.36 | ₹0.55 | ₹0.20 | ₹0.36 | ₹0.48 |
|---|
| Diluted EPS | ₹0.36 | ₹0.55 | ₹0.20 | ₹0.36 | ₹0.48 |
|---|
AAREYDRUGS results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | -56.3% | — | — | — | — |
|---|
| Revenue QoQ | -76.4% | +96.5% | +14.6% | -17.7% | — |
|---|
| Operating profit YoY | -61.0% | — | — | — | — |
|---|
| Operating profit QoQ | -86.4% | +249.4% | -220.0% | +60.2% | — |
|---|
| Net profit YoY | -25.3% | — | — | — | — |
|---|
| Net profit QoQ | -34.3% | +173.5% | -44.4% | -25.3% | — |
|---|
| EPS YoY | -25.0% | — | — | — | — |
|---|
| EPS QoQ | -34.5% | +175.0% | -44.4% | -25.0% | — |
|---|
AAREYDRUGS annual results history
Full-year performance for AAREY DRUGS & PHARM LTD, useful for reading each quarter in context.
AAREY DRUGS & PHARM LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹472 cr | ₹474 cr | ₹395 cr | ₹413 cr |
|---|
| Total expenses | ₹468 cr | ₹473 cr | ₹392 cr | ₹411 cr |
|---|
| Gross profit | ₹17.76 cr | ₹11.88 cr | ₹13.2 cr | ₹9.01 cr |
|---|
| Operating profit (EBIT) | ₹4.32 cr | ₹0.95 cr | ₹2.82 cr | ₹2 cr |
|---|
| Operating margin | 0.9% | 0.2% | 0.7% | 0.5% |
|---|
| Interest cost | ₹5 cr | ₹4.66 cr | ₹4.31 cr | ₹2.61 cr |
|---|
| Profit before tax | ₹5.41 cr | ₹6.1 cr | ₹5.34 cr | ₹6.01 cr |
|---|
| Tax expense | ₹1.45 cr | ₹2.08 cr | ₹0.66 cr | ₹2.24 cr |
|---|
| Effective tax rate | 26.7% | 34.1% | 12.3% | 37.3% |
|---|
| Net profit (PAT) | ₹3.97 cr | ₹4.02 cr | ₹4.68 cr | ₹3.77 cr |
|---|
| Net profit margin | 0.8% | 0.8% | 1.2% | 0.9% |
|---|
| Basic EPS | ₹1.39 | ₹1.42 | ₹1.84 | ₹1.49 |
|---|
| Diluted EPS | ₹1.39 | ₹1.42 | ₹1.84 | ₹1.49 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹44.63 cr against ₹102 cr in Q1 FY26, and ₹189 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -76.4%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹44.15 cr, or 98.9% of revenue, with operating profit declined -61.0% year on year.
Margins, tax and profitability
Net profit of ₹1.02 cr works out to a net margin of 2.3% compared with 1.3% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, AAREY DRUGS & PHARM LTD reported profit before tax of ₹0.52 cr, a tax charge of -₹0.51 cr (effective rate -98.5%), interest cost of ₹1.67 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹1.56 cr in Q4 FY26 to ₹1.02 cr in Q1 FY27, a change of -34.3%.
Trailing twelve months and annual context
Across the trailing four quarters AAREY DRUGS & PHARM LTD has generated revenue of ₹415 cr and net profit of ₹4.17 cr, a trailing net margin of 1.0%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹472 cr with net profit of ₹3.97 cr and EPS of ₹1.39, versus the prior year where revenue declined -0.4% and profit declined -1.4%.
What to watch in the next AAREYDRUGS quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
AAREY DRUGS & PHARM LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
AAREYDRUGS results coverage
No results report published for AAREYDRUGS yet — our desk covers each quarter within minutes of the filing.
AAREYDRUGS quarterly results FAQs
What were AAREY DRUGS & PHARM LTD (AAREYDRUGS) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), AAREY DRUGS & PHARM LTD reported revenue of ₹44.63 cr and net profit of ₹1.02 cr, a change of -25.3% year on year on -56.3% revenue growth. EPS stood at ₹0.36.
What is AAREYDRUGS profit margin in Q1 FY27?
AAREY DRUGS & PHARM LTD posted a net profit margin of 2.3% and an operating margin of 1.1% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹415 cr and net profit ₹4.17 cr.
Did AAREYDRUGS results beat the previous quarter?
AAREY DRUGS & PHARM LTD net profit changed -34.3% quarter on quarter, from ₹1.56 cr in Q4 FY26 to ₹1.02 cr in Q1 FY27.
When are AAREY DRUGS & PHARM LTD (AAREYDRUGS) quarterly results?
AAREY DRUGS & PHARM LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see AAREYDRUGS latest quarterly results?
Results coverage for AAREYDRUGS will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the AAREYDRUGS stock page.
What is AAREY DRUGS & PHARM LTD annual revenue and profit?
For FY26, AAREY DRUGS & PHARM LTD reported full-year revenue of ₹472 cr and net profit of ₹3.97 cr, with EPS of ₹1.39.
How many quarterly results has AAREYDRUGS declared recently?
Past results dates for AAREYDRUGS will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
